Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Pancreatic
Study Phase
Phase 2B
Study Completion Date
December 2013
NCT01016483Uploaded 12-16-2020
Available for Download
PDS UID: Pancrea_EMDSero_2009_442
Phase II Randomized Trial of MEK Inhibitor MSC1936369B or Placebo Combined With Gemcitabine in Metastatic Pancreas Cancer Subjects
Files:
PROTOCOLEMR200066-003 CTP V7.0 20Mar2013 fully signed_Redacted.pdf
CRFMEKi003_24May2013_Version_3.0_eCRF.pdf
DATA DICTIONARYdatadict.xpt
DATA SUMMARYDescriptive_Stats_EMR 200066-003.xlsx
DATA SUMMARYProc Contents Data Dictionary EMR 200066-003.pdf
DATA (COMPARATOR ARM)DATA.zip
DATA (COMPARATOR ARM)DATA_XPT.zip